DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20212368

Successful treatment of clear cell carcinoma of ovary during pregnancy: a case report

Preethi Ashok, Kalaichelvi Kannan

Abstract


The incidence of malignant ovarian tumor is rare during pregnancy. Most women hope to maintain the pregnancy and preserve fertility thus increasing the need for standard guidelines regarding surgery and chemotherapy for safe oncologic and fetal outcomes. Here we present a 30-years-old primigravida, diagnosed with bilateral ovarian mass during routine ultrasound imaging at 8 weeks of gestation. CA125 was 14.2 U/ml. MRI pelvis taken at 13 weeks showed bilateral complex cystic masses with internal septations. The patient underwent bilateral salphingo-oopherectomy and infracolic omentectomy during 18th week of gestation, the histopathology showing clear cell carcinoma with capsular invasion and microscopic omental deposit thus staged as IIIA. She was planned for adjuvant chemotherapy comprising of paclitaxel and carboplatin during the 21st week along with serial ultrasounds for fetal monitoring. After 5 cycles, at 37 weeks of gestation, she was taken up for elective LSCS followed by completion of surgery for ovarian malignancy, that is, hysterectomy with bilateral pelvic lymphadectomy. Endometrium showed gestational changes with all lymph nodes being negative for tumor deposits. A healthy male child weighing 3.4 kg was delivered. She was given 6th cycle of chemotherapy post-surgery and two years later, mother and baby are doing well and on regular follow up. Thus, the successful treatment of clear cell ovarian carcinoma in this woman with safe pregnancy outcomes can be attributed to timely diagnosis and feasibility of surgery and chemotherapy during second trimester.


Keywords


Ovarian cancer, Pregnancy, Clear cell carcinoma, Chemotherapy, Staging

Full Text:

PDF

References


Farahmand SM, Marchetti DL, Asirwatham JE, Dewey MR. Ovarian endodermal sinus tumor associated with pregnancy: review of the literature. Gynecol Oncol. 1991;41(2):156-60.

Whitecar MP, Turner S, Higby MK. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol. 1999;181(1):19-24.

Jacob JH, Stringer CA. Diagnosis and management of cancer during pregnancy. Semin Perinatol. 1990;14(1):79-87.

Zanotti KM, Belinson JL, Kennedy AW. Treatment of gynecologic cancers in pregnancy. Semin Oncol. 2000;27(6):686-98.

Lavery JP, Koontz WL, Layman L, Shaw L, Gumpel U. Sonographic evaluation of the adnexa during early pregnancy. Surg Gynecol Obstet. 1986;163(4):319-23.

Hogston P, Lilford RJ. Ultrasound study of ovarian cysts in pregnancy: prevalence and significance. Br J Obstet Gynaecol. 1986;93(6):625-8.

Hopkins MP, Duchon MA. Adnexal surgery in pregnancy. J Reprod Med. 1986;31(11):1035-7.

Elit L, Bocking A, Kenyon C, Natale R. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol. 1999;72(1):123-7.

Dgani R, Shoham Z, Atar E, Zosmer A, Lancet M. Ovarian carcinoma during pregnancy: a study of 23 cases in Israel between the years 1960 and 1984. Gynecol Oncol. 1989;33(3):326-31.

Copeland LJ, Landon MB. Malignant disease in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics, Normal And Problem Pregnancies. 3rd ed. New York, NY: Churchill Livingstone; 1996: 1155-1181.

Behtash N, Karimi ZM, Modares GM, Ghaemmaghami F, Mousavi A, Ghotbizadeh F. Ovarian carcinoma associated with pregnancy: a clinicopathologic analysis of 23 cases and review of the literature. BMC Pregnancy Childbirth. 2008;8:3.

Bakri YN, Ezzat A, Akhtar, Dohami, Zahrani. Malignant germ cell tumors of the ovary. Pregnancy considerations. Eur J Obstet Gynecol Reprod Biol. 2000;90(1):87-91.

Williams SD, Gershenson DM, Horowitz CJ. Ovarian germ-cell tumors. In: Hoskins WJ, Perez CA, Young RC, eds. Principles And Practice Of Gynaecologic Oncology. Philadelphia, PA: Lippincott; 1996: 987-1001.

Lerner JP, Timor TIE, Federman A, Abramovich G. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol. 1994;170(1):81-5.

Dudkiewicz J, Kowalski T, Grzonka D, Czarnecki M. Ovarian tumors in pregnancy. Ginekol Pol. 2002;73(4):342-5.

Katz VL, Watson WJ, Hansen WF, Washington JL. Massive ovarian tumor complicating pregnancy. A case report. J Reprod Med. 1993;38(11):907-10.

Pitynski K, Basta A, Szczudrawa A, Opławski M. Ovarian tumors in pregnancy in the material of the Department of Gynecology and Oncology Collegium Medicum of Jagiellonian University in Cracow. Ginekol Pol. 2002;73(4):371-5.

Ueda M, Ueki M. Ovarian tumors associated with pregnancy. Int J Gynaecol Obstet. 1996;55(1):59-65.

Agarwal N, Parul, Kriplani A, Bhatla N, Gupta A. Management and outcome of pregnancies complicated with adnexal masses. Arch Gynecol Obstet. 2003;267(3):148-52.

Grendys EC, Barnes WA. Ovarian cancer in pregnancy. Surg Clin North Am. 1995;75(1):1-14.

Lowe SA. Diagnostic radiography in pregnancy: risks and reality. Aust NZJ Obstet Gynaecol. 2004;44:191-6.

Shellock FG, Kanal E. Policies, guidelines, and recommendations for MR imaging safety and patient management. SMRI Safety Committee. J Magn Reson Imaging. 1991;1(1):97-101.

ACOG Committee on Obstetric Practice. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol. 2004;104(3):647-51.

Otton G, Higgins S, Phillips KA, Quinn M. A case of early-stage epithelial ovarian cancer in pregnancy. Int J Gynecol Cancer. 2001;11(5):413-7.

Kobayashi F, Sagawa N, Nakamura K, Nonogaki M, Ban C, Fujii S, Mori T. Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol. 1989;160(3):563-6.

Machado F, Vegas C, Leon J, Perez A, Sanchez R, Parrilla JJ, et al. Ovarian cancer during pregnancy: analysis of 15 cases. Gynecol Oncol. 2007;105(2):446-50.

Ghaemmaghami F, Hasanzadeh M. Good fetal outcome of pregnancies with gynecologic cancer conditions: cases and literature review. Int J Gynecol Cancer. 2006;16(1):225-30.

Tabata T, Nishiura K, Tanida K, Kondo E, Okugawa T, Sagawa N. Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. Int J Gynecol Cancer. 2008;18(1):181-4.

Leslie KK. Chemotherapy and pregnancy. Clin Obstet Gynecol. 2002;45(1):153-64.

Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke PD, Burger RA, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2003;21(17):3194-200.

Kai S, Kohmura H, Ishikawa K, Takeuchi Y, Ohta S, Kuroyanagi K, et al. Reproduction studies of carboplatin (II)--Intravenous administration to rats during the period of fetal organogenesis. J Toxicol Sci. 1988;13(2):35-61.

Kai S, Kohmura H, Ishikawa K, Makihara Y, Ohta S, Kawano S, et al. Teratogenic effects of carboplatin, an oncostatic drug, administered during the early organogenetic period in rats. J Toxicol Sci. 1989;14(2):115-30.

Kai S, Kohmura H, Hiraiwa E, Koizumi S, Ishikawa K, Kawano S, et al. Reproductive and developmental toxicity studies of paclitaxel. (III)--Intravenous administration to rats during the perinatal and lactation periods. J Toxicol Sci. 1994;19(1):93-111.

Williams SF, Bitran JD. Cancer and pregnancy. Clin Perinatol. 1985;12(3):609-23.

Hubalek M, Smekal SC, Zeimet AG, Sergi C, Brezinka C, Mueller HE, Marth C. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma. Arch Gynecol Obstet. 2007;276(2):179-83.

Brewer M, Kueck A, Runowicz CD. Chemotherapy in pregnancy. Clin Obstet Gyneco.l 2011;54(4):602-18.

Patsner B, Mann WJ, Chumas J. Primary invasive ovarian adenocarcinoma with brain and placental metastases: a case report. Gynecol Oncol. 1989;33:112-5.

Ishioka S, Hayashi T, Endo T, Baba T, Honma H, Saito T. Advanced epithelial ovarian carcinoma during pregnancy. Int J Clin Oncol. 2007;12(5):375-8.